New cream shows promise for controlling severe eczema flares

NCT ID NCT05014568

Completed Disease control Sponsor: Organon and Co Source: ClinicalTrials.gov ↗

Summary

This study tested a new topical cream called tapinarof for people with moderate to severe eczema (atopic dermatitis). Over 400 children and adults applied the cream or a placebo once daily for 8 weeks to see if it could clear or nearly clear their skin and reduce itching. The goal was to see if this new treatment could effectively control the disease and was safe for long-term use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Dermavant Investigative Site

Birmingham, Alabama, 35244, United States
Dermavant Investigative Site

Phoenix, Arizona, 85032, United States
Dermavant Investigative Site

Bryant, Arkansas, 72022, United States
Dermavant Investigative Site

Beverly Hills, California, 90212, United States
Dermavant Investigative Site

Fountain Valley, California, 92708, United States
Dermavant Investigative Site

Fremont, California, 94538, United States
Dermavant Investigative Site

Inglewood, California, 90301, United States
Dermavant Investigative Site

Los Angeles, California, 90017, United States
Dermavant Investigative Site

Los Angeles, California, 90033, United States
Dermavant Investigative Site

Mission Viejo, California, 92691, United States
Dermavant Investigative Site

Sacramento, California, 95815, United States
Dermavant Investigative Site

Washington D.C., District of Columbia, 20037, United States
Dermavant Investigative Site

Boca Raton, Florida, 33431, United States
Dermavant Investigative Site

Boca Raton, Florida, 33486, United States
Dermavant Investigative Site

Brandon, Florida, 33511, United States
Dermavant Investigative Site

Coral Gables, Florida, 33146, United States
Dermavant Investigative Site

Jacksonville, Florida, 32256, United States
Dermavant Investigative Site

Margate, Florida, 33063, United States
Dermavant Investigative Site

Miami, Florida, 33126, United States
Dermavant Investigative Site

Miami Lakes, Florida, 33014, United States
Dermavant Investigative Site

Orlando, Florida, 32801, United States
Dermavant Investigative Site

Pinellas Park, Florida, 33781, United States
Dermavant Investigative Site

Sweetwater, Florida, 33172, United States
Dermavant Investigative Site

Tampa, Florida, 33615, United States
Dermavant Investigative Site

Marietta, Georgia, 30060, United States
Dermavant Investigative Site

Sandy Springs, Georgia, 30328, United States
Dermavant Investigative Site

Savannah, Georgia, 31406, United States
Dermavant Investigative Site

Plainfield, Indiana, 46168, United States
Dermavant Investigative Site

Louisville, Kentucky, 40217, United States
Dermavant Investigative Site

Owensboro, Kentucky, 42301, United States
Dermavant Investigative Site

Covington, Louisiana, 70433, United States
Dermavant Investigative Site

Monroe, Louisiana, 71201, United States
Dermavant Investigative Site

Largo, Maryland, 20774, United States
Dermavant Investigative Site

Bay City, Michigan, 48706, United States
Dermavant Investigative Site

Clarkston, Michigan, 48346, United States
Dermavant Investigative Site

Warren, Michigan, 48088, United States
Dermavant Investigative Site

Ypsilanti, Michigan, 48197, United States
Dermavant Investigative Site

New Brighton, Minnesota, 55112, United States
Dermavant Investigative Site

Missoula, Montana, 59808, United States
Dermavant Investigative Site

Omaha, Nebraska, 68144, United States
Dermavant Investigative Site

Garden City, New York, 11530, United States
Dermavant Investigative Site

New York, New York, 10075, United States
Dermavant Investigative Site

Bexley, Ohio, 43209, United States
Dermavant Investigative Site

Cleveland, Ohio, 44106, United States
Dermavant Investigative Site

Oklahoma City, Oklahoma, 73071, United States
Dermavant Investigative Site

Oklahoma City, Oklahoma, 73120, United States
Dermavant Investigative Site

Gresham, Oregon, 97030, United States
Dermavant Investigative Site

Portland, Oregon, 97223, United States
Dermavant Investigative Site

Hershey, Pennsylvania, 17033, United States
Dermavant Investigative Site

Greenville, South Carolina, 29615, United States
Dermavant Investigative Site

Knoxville, Tennessee, 37909, United States
Dermavant Investigative Site

Austin, Texas, 78745, United States
Dermavant Investigative Site

Bellaire, Texas, 77401, United States
Dermavant Investigative Site

Cypress, Texas, 77433, United States
Dermavant Investigative Site

Dallas, Texas, 75230, United States
Dermavant Investigative Site

Houston, Texas, 77098, United States
Dermavant Investigative Site

San Antonio, Texas, 78218, United States
Dermavant Investigative Site

San Antonio, Texas, 78229, United States
Dermavant Investigative Site

Sugar Land, Texas, 77479, United States
Dermavant Investigative Site

Richmond, Virginia, 23226, United States
Dermavant Investigative Site

Winnipeg, Manitoba, R3M 3Z4, Canada
Dermavant Investigative Site

Burlington, Ontario, L7L 6W6, Canada
Dermavant Investigative Site

Cobourg, Ontario, K9A 0Z4, Canada
Dermavant Investigative Site

Hamilton, Ontario, L8S 1G5, Canada
Dermavant Investigative Site

Oakville, Ontario, L6J 7W5, Canada
Dermavant Investigative Site

Ottawa, Ontario, K2C 3N2, Canada
Dermavant Investigative Site

Montreal, Quebec, H2X 2V1, Canada

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS